Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689386011 | Agalsidase beta 35 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689387019 | Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3598011000005117 | agalsidase beta 35 mg pulver til injektionsvæske, opløsning, hætteglas | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | dansk modul |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Agalsidase beta 35 mg powder for solution for injection vial | Is a | Product containing agalsidase beta (medicinal product) | false | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has active ingredient | Alpha-galactosidase | false | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has manufactured dose form | injektionsvæske | false | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has active ingredient | biologisk middel | false | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has active ingredient | Agalsidase beta (substance) | false | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Agalsidase beta 35 mg powder for solution for injection vial | Count of base of active ingredient | en | false | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has precise active ingredient | Agalsidase beta (substance) | true | Inferred relationship | Some | 1 | |
| Agalsidase beta 35 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Agalsidase beta (substance) | true | Inferred relationship | Some | 1 | |
| Agalsidase beta 35 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Agalsidase beta 35 mg powder for solution for injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Agalsidase beta 35 mg powder for solution for injection vial | Has presentation strength numerator value | 35 | false | Inferred relationship | Some | 1 | |
| Agalsidase beta 35 mg powder for solution for injection vial | Has presentation strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Agalsidase beta 35 mg powder for solution for injection vial | Is a | Agalsidase beta only product in parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR